DOCSLIB.ORG

A Review on Co-Processed Excipients: Current and Future Trend of Excipient Technology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Review on Co-Processed Excipients: Current and Future Trend of Excipient Technology International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 11, Issue 1, 2019 Review Article A REVIEW ON CO-PROCESSED EXCIPIENTS: CURRENT AND FUTURE TREND OF EXCIPIENT TECHNOLOGY LIEW KAI BINab*, ANAND GAURAVa, UTTAM KUMAR MANDALc aFaculty of Pharmaceutical Sciences, UCSI University. No 1, Jalan Menara Gading, UCSI Height, 56000 Cheras, Kuala Lumpur, bFaculty of Pharmacy, Cyberjaya University College of Medical Sciences. Persiaran Bestari, 63000 Cyberjaya, Selangor, cDepartment of Pharmaceutical Sciences and Technology, Maharaja Ranjit Singh Punjab Technical University (MRSPTU), Bathinda, Punjab 151001, India Email: [email protected] Received: 21 Aug 2018 Revised and Accepted: 23 Nov 2018 ABSTRACT There is no single-component excipient fulfills all the requisite performance to allow an active pharmaceutical ingredient to be formulated into a specific dosage form. Co-processed excipient has received much more attention in the formulation development of various dosage forms, specially for tablet preparation by direct compression method. The objective of this review is to discuss the emergence of co-processed excipients as a current and future trend of excipient technology in pharmaceutical manufacturing. Co-processing is a novel concept of combining two or more excipients that possess specific advantages that cannot be achieved using a physical admixture of the same combination of excipients. This review article discusses the advantages of co-processing, the need of co-processed excipient, general steps in developing co-processed excipient, limitation of co-processed excipient, technologies used in developing co-processing excipients, co-processed excipients in the literature, marketed products and future trends. With advantages offered by the upcoming newer combination of excipients and newer methods of co-processing, co-processed excipients are for sure going to gain attraction both from academia and pharmaceutical industry. Furthermore, it opens the opportunity for development and use of single multifunctional excipient rather than multiple excipients in the formulation. Keywords: Orally disintegrating tablet, Oral drug delivery, Co-processed excipient, Direct compression © 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open-access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) DOI: http://dx.doi.org/10.22159/ijpps.2019v11i1.29265 INTRODUCTION processing. However, in the case of co-processed excipients, they possess performance advantages that cannot be achieved using a In the past 10 y, the focus of both academia and pharmaceutical physical admixture of the same combination of excipients [11]. industry has been shifted from developing new active Combination of economical excipient with others of optimal quantity pharmaceutical ingredient (API) to formulation technology [1]. of a functional material will produce an integrated product with Pharmaceutical excipients have played a major role in that shift. superior functionality than the simple mixture of components [12]. Pharmaceutical excipients are defined as the substances other than Co-processing generally does not involve chemical change. The the API which has been appropriately evaluated for safety and are changes in functionality are often contributed by the change in intentionally included in a drug delivery system [2]. The physical properties of the excipient particles [13]. International Pharmaceutical Excipients Council (2009) defines excipients as the substances which present in a finished Oral delivery remains the most popular route of drug delivery [14]. pharmaceutical dosage form other than the active drug substance It is because the oral drug delivery system has the key advantage of [3]. Excipient can be classified into four categories generally: single convenient drug administration. Tablets and hard gelatin capsules entity excipient, a physical blend of multiple excipients, new constitute a major portion of drug delivery systems that are chemical entity excipient and co-processed excipient [4]. currently available due to its convenience of self-administration, compactness and simple manufacturing process [15, 16]. Moreover, It is generally agreed by the formulation scientist that there is no the drug is found to be more stable in solid dosage form than liquid single-component excipient fulfills all the requisite performance to dosage form [17]. allow an active pharmaceutical ingredient to be formulated into a specific dosage form [5]. On the other hand, developing a new The most common methods to manufacture tablets are wet chemical entity excipient requires a huge sum of investment [6]. To granulation, dry granulation and direct compression [18]. If the counter this issue, formulation scientist has introduced a novel major components of a formulation have already possessed good concept of co-processing which is combining of two or more fluidity and compressibility, granulation would be redundant. Direct excipients that possess significant advantages that cannot be compression was reported as one of the most preferred methods achieved using a physical admixture of the same combination of due to some advantages such as time-saving, ease of production due excipients [7]. A co-processed excipient is a combination of two or to few steps involved, the absence of heat and moisture in the more compendial or non-compendial excipients designed to modify process [19]. In the survey by Shangraw and Damarest (1993), it their physical properties in a manner not achievable by simple was shown that direct compression was the most preferred tablet physical mixing, and without significant chemical change [2]. By manufacturing method compared to wet granulation and roller formulating few excipients into a single composite material with compaction. About 41% of the companies indicated that direct specialized manufacturing method leads to an improvement in compression was the method of choice, and 41.1% indicated that functionality of the end product [8]. This has become a newer trend they used both direct compression and wet granulation. Only 1.7% in formulation development [9]. of the respondents indicated that they never used direct compression and 15.5% indicated that the process was not Co-processed excipient has received much more attention in the recommended [19]. formulation development of various dosage forms such as a tablet, capsule, powder, cream, ointment, and others [10]. It is different A further advantage of direct compression is that tablets disintegrate from the physical mixture. Physical mixture is just a simple into the primary particles bypassing granular aggregation stage. As a admixture combining few excipients by short duration shear result, the effective surface area increases and dissolution of the drug Liew et al. Int J Pharm Pharm Sci, Vol 11, Issue 1, 1-9 become faster [20]. However, the method encounters drawbacks due processed adjuvants, by virtue of their high solubility, swelling and to lack of suitable excipients for direct compression application. Two wicking property, provide rapid disintegration to the developed major factors of powder characteristic which will critically affect the formulation. process of direct compression are compressibility and flowability [21, 22]. The majority of the excipients that are currently available fail to Stability meet the desired set of functionalities. It creates urgency for the The co-processed excipient should be stable physically and chemically development of high functionality excipients [23]. Therefore, the co- [6]. The ingredients used should be inert and not interact with the API. processed excipient can play a role here to fill the gap of technology in direct compression. Cost saving The aim of this article was to perform a literature review on co- The manufacturer uses a single excipient with multiple functional processed excipient and compile as well as discussing the co- properties, thereby reducing the number of excipients used and processed excipients available in the market and in literature. A labor cost involved in their processing other than direct detail literature review was conducted by searching keywords such compression method. Use of co-processed adjuvants simplifies as: a co-processed excipient, orally disintegrating tablet, oral drug manufacturing process which leads to time and cost saving. delivery, tablet, direct compression, formulation, solid dosage form and powder. The search was done in the search engines including Need of co-processed excipients Science Direct, Science and Technology of Advanced Materials, PLOS A list of available co-processed excipients is provided in table 1. However, ONE, Directory of Open Access Journals, CiteSeer and Google Scholar. they are not sufficient considering the diverse need of the pharmaceutical industries, specially for preparation of ODT tablets. Advantages of co-processing There are only a few excipients are suitable for direct compression Improved compressibility application. Most of the excipients having drawbacks such as lack of compressibility, poor flowability, lack of cohesion properties or Compressibility is an important factor of consideration in tablet lubrication [32]. As a result, a blend of few ingredients is required to development. Ideally, a compacted tablet is formed once the achieve satisfactory condition prior to direct compression [33]. compression force is removed (6). However, all the conventional tablet Moreover, the advance in
Load more

Recommended publications
  • An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: a Review
    Muthadi Radhika Reddy /J. Pharm. Sci. & Res. Vol. 12(7), 2020, 925-940 An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: A Review Muthadi Radhika Reddy1* 1School of pharmacy, Gurunanak Institute of Technical Campus, Hyderabad, Telangana, India and Department of Pharmacy, Gandhi Institute of Technology and Management University, Vizag, Andhra Pradesh, India INTRODUCTION 2. Useful in situations where rapid onset of action Fast dissolving drug delivery systems were first developed required such as in motion sickness, allergic attack, in the late 1970s as an alternative to conventional dosage coughing or asthma forms. These systems consist of solid dosage forms that 3. Has wide range of applications in pharmaceuticals, Rx disintegrate and dissolve quickly in the oral cavity without Prescriptions and OTC medications for treating pain, the need of water [1]. Fast dissolving drug delivery cough/cold, gastro-esophageal reflux disease,erectile systems include orally disintegrating tablets (ODTs) and dysfunction, sleep disorders, dietary supplements, etc oral thin films (OTFs). The Centre for Drug Evaluation [4] and Research (CDER) defines ODTs as,“a solid dosage 4. No water is required for the administration and hence form containing medicinal substances which disintegrates suitable during travelling rapidly, usually within a matter of seconds, when placed 5. Some drugs are absorbed from the mouth, pharynx upon the tongue” [2]. USFDA defines OTFs as, “a thin, and esophagus as the saliva passes down into the flexible, non-friable polymeric film strip containing one or stomach, enhancing bioavailability of drugs more dispersed active pharmaceutical ingredients which is 6. May offer improved bioavailability for poorly water intended to be placed on the tongue for rapid soluble drugs by offering large surface area as it disintegration or dissolution in the saliva prior to disintegrates and dissolves rapidly swallowing for delivery into the gastrointestinal tract” [3].
    [Show full text]
  • The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability
    pharmaceutics Review The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability Jannes van der Merwe, Jan Steenekamp, Dewald Steyn and Josias Hamman * Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), North-West University, Private Bag X6001, Potchefstroom 2520, South Africa; [email protected] (J.v.d.M.); [email protected] (J.S.); [email protected] (D.S.) * Correspondence: [email protected]; Tel.: +27-18-299-4035 Received: 28 February 2020; Accepted: 21 April 2020; Published: 25 April 2020 Abstract: Many active pharmaceutical ingredients (APIs) exhibit poor solubility and low dissolution rates in aqueous environments such as the luminal fluids of the gastrointestinal tract. The oral bioavailability of these compounds is usually very low as a result of their poor solubility properties. In order to improve the bioavailability of these poorly soluble drugs, formulation strategies have been applied as a means to improve their aqueous solubility and dissolution rates. With respect to formulation approaches, excipients can be incorporated in the formulation to assist in the dissolution process of the drug, or specialized dosage forms can be formulated that improve dissolution rate through various mechanisms. This paper provides an overview of selected excipients (e.g., alkalinizing agents, surfactants and sugars) that can be used in formulations to increase the dissolution rate as well as specialized dosage forms such as self-emulsifying delivery systems and formulation techniques such as inclusion complexes and solid dispersions. These formulation approaches are discussed with available examples with specific reference to positive outcomes in terms of drug solubility and bioavailability enhancement.
    [Show full text]
  • Influence of Mannitol Concentration on the Physicochemical, Mechanical and Pharmaceutical Properties of Lyophilised Mannitol
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Wolverhampton Intellectual Repository and E-theses Accepted Manuscript Title: Influence of mannitol concentration on the physicochemical, mechanical and pharmaceutical properties of lyophilised mannitol Author: Waseem Kaialy Usman Khan Shadan Mawlud PII: S0378-5173(16)30441-0 DOI: http://dx.doi.org/doi:10.1016/j.ijpharm.2016.05.052 Reference: IJP 15791 To appear in: International Journal of Pharmaceutics Received date: 30-3-2016 Revised date: 23-5-2016 Accepted date: 26-5-2016 Please cite this article as: Kaialy, Waseem, Khan, Usman, Mawlud, Shadan, Influence of mannitol concentration on the physicochemical, mechanical and pharmaceutical properties of lyophilised mannitol.International Journal of Pharmaceutics http://dx.doi.org/10.1016/j.ijpharm.2016.05.052 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Influence of mannitol concentration on the physicochemical, mechanical and pharmaceutical properties of lyophilised mannitol Waseem Kaialy*, Usman Khan, Shadan Mawlud School of Pharmacy, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, WV1 1LY, UK *Corresponding author Waseem Kaialy, Tel: +441902321139, E-mail: [email protected] 1 Graphical Abstract 2 Abstract Mannitol is a pharmaceutical excipient that is receiving increased popularity in solid dosage forms.
    [Show full text]
  • Oral Films: a Comprehensive Review
    Mahboob et al., International Current Pharmaceutical Journal, November 2016, 5(12): 111-117 International Current http://www.icpjonline.com/documents/Vol5Issue12/03.pdf Pharmaceutical Journal REVIEW ARTICLE OPEN ACCESS Oral Films: A Comprehensive Review *Muhammad Bilal Hassan Mahboob1,2, Tehseen Riaz1,2, Muhammad Jamshaid1, Irfan Bashir1,2 and Saqiba Zulfiqar1,2,3 1Faculty of Pharmacy, University of Central Punjab Lahore, Pakistan 2Foundation for Young Researchers, Pakistan 3Shoukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan ABSTRACT In the late 1970s, rapid disintegrating drug delivery system was developed as an alternative to capsules, tablets and syrups for geriatric and pediatric patients having problems in swallowing. To overcome the need, number of orally disintegrating tablets which disinte- grate within one minute in mouth without chewing or drinking water were commercialized. Then later, oral drug delivery technology had been improved from conventional dosage form to modified release dosage form and developed recently rapid disintegrating films rather than oral disintegrating tablets. Oral disintegrating film or strips containing water dissolving polymer retain the dosage form to be quickly hydrated by saliva, adhere to mucosa, and disintegrate within a few seconds, dissolve and releases medication for oro- mucosal absorption when placed in mouth. Oral film technology is the alternative route with first pass metabolism. This review give a comprehensive detail of materials used in ODF, manufacturing process, evaluation tests and marketed products. Key Words: Oral disintegrating film, oral strip, pediatric and geriatric patients. INTRODUCTIONINTRODUCTION An oral film or strips are manufactured as a large Oral administration is the most preferred route due to re- sheet and then cut into individual dosage unit for packag- lieve of ingestion, pain reduction, to accommodate various ing (Desai et al., 2012).
    [Show full text]
  • Rita Corporation » Your Source for Specialty Chemicals Worldwide
    Products catalogue Products Pharmacy Cosmetics Industry Petroleum jellies I Gels White oils I Paraffins GROUPE Aiglon, a constantly developing, independent family business group The Aiglon group is the only French specialist in Pharmacology and cosmetology, manufacturing petroleum jellies, waxes, gels, oils key sectors and technical products. Aiglon’s proven skills and constant research for innovation has earned Aiglon sells its products to the largest French the company worldwide renown. Aiglon’s and international pharmaceutical and cosmetic quality standards are above the requirements companies. of the principle market standards. The ongoing investment efforts and the highly qualified research team make it a leading company in its field, resolutely turned towards the future. Pharmaceutical industry: 40% High quality service Cosmetic industry: 40% Petroleum jelly, leading product Identification of customer needs Industrial applications: 20% Aiglon, the only manufacturer in France and Proven skills the only GMP company in the market, offers the largest range of petroleum jellies on the Implementation assistance market and develops tailor-made products. Modern production facilities Aiglon petroleum jellies are of exceptional purity and stability. They are made according The laboratory is managed by two Ph D Personalised supply chain to the requirements of the French Codex chemistry engineers and is equipped with Pharmacopoeia which is much stricter than in high quality scientific material. Tailor-made solutions any other country in the world. In pharmaceutics, The annual production capacity of 20 000 they are the only ones authorised for oral use. tonnes guarantees the security and continuity Quality and after sales monitoring They are non-comedogenic. of supply. The capacities of the 5 petroleum The manufacture of petroleum jelly is a jelly blenders offer a large batch size choice complex alchemy.
    [Show full text]
  • Excipients in Children's Medicines
    information for parents and carers Excipients in children’s medicines This leaflet is about the common ingredients (‘excipients’) used to make up children’s medicines What are excipients? Are there any risks with particular excipients? All forms of medicine contain ingredients as well as the • All excipients have been reviewed by the healthcare drug – these are called excipients. Excipients don’t have any regulatory agencies to make sure they are generally medical effect but they are needed for a variety of reasons: safe for use in human medicine. Some patients may want to avoid particular excipients • To improve the taste - sugar, artificial sweeteners or • flavouring may be added to liquid medicine to make for a variety of reasons. them taste better. • You should tell your doctor or pharmacist if your child needs to avoid a particular excipient, as they may be • To improve the texture - thickening agents may be added to liquid medicines so that they are easier to pour. able to provide a different version of the medicine. However, most medicines contain only very small • To dissolve the medicine - small amounts of ethanol • (alcohol) may be used to help a drug dissolve to make a amounts of excipients that are unlikely to cause any liquid medicine. problems. • To make them easier to handle - special powder can be used to bulk up tablets to make them large enough to Tell your pharmacist if your child needs to avoid handle, as the amount of drug is usually tiny. any of the following excipients: To make them work better - other ingredients might be • Used to dissolve some medicines, added to tablets to help them break up properly in the • Peanut oil (Arachis): particularly vitamin D drops.
    [Show full text]
  • Effects of Formulation Excipients on Skin Barrier Function in Creams
    pharmaceutics Article Effects of Formulation Excipients on Skin Barrier Function in Creams Used in Pediatric Care Anita Kovács 1,Dóra Péter-Héderi 1, Katalin Perei 2,Mária Budai-Sz ˝ucs 1 , Attila Léber 1, Attila Gácsi 1, Erzsébet Csányi 1 and Szilvia Berkó 1,* 1 Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary; [email protected] (A.K.); [email protected] (D.P.-H.); [email protected] (M.B.-S.); [email protected] (A.L.); [email protected] (A.G.); [email protected] (E.C.) 2 Department of Biotechnology, University of Szeged, Közép fasor 52, 6726 Szeged, Hungary; [email protected] * Correspondence: [email protected] Received: 30 June 2020; Accepted: 31 July 2020; Published: 4 August 2020 Abstract: Semisolid dosage forms are recommended for the dermal care of babies and children. If we look at the ingredients of these preparations, there are still many cases in which there are substances (occlusive agents, preservatives) that no longer meet certain requirements of the modern age, so it is timely to replace them with other substances. The aim of this work was to formulate a science-based formulation with new components that keep or improve its moisturizing properties, rheological parameters, and microbiological stability. Occlusive oils, like white petrolatum and liquid paraffin and the preservative parabens are traditional ingredients in oil in water creams, were replaced with white beeswax, sunflower oil, and phenoxyethanol, respectively. Cocoa butter, urea, and glycerol were added to improve long-lasting hydration and support the barrier function of the reformulated creams.
    [Show full text]
  • Oral Films - Patient Compliant Dosage Form for Pediatrics S Malke, S Shidhaye, J Desai, V Kadam
    The Internet Journal of Pediatrics and Neonatology ISPUB.COM Volume 11 Number 2 Oral Films - Patient Compliant Dosage Form For Pediatrics S Malke, S Shidhaye, J Desai, V Kadam Citation S Malke, S Shidhaye, J Desai, V Kadam. Oral Films - Patient Compliant Dosage Form For Pediatrics. The Internet Journal of Pediatrics and Neonatology. 2009 Volume 11 Number 2. Abstract Pediatric and geriatric patients, have difficulty swallowing or chewing solid dosage forms. Many pediatric and geriatric patients are unwilling to take solid preparations due to fear of choking. Even with fast dissolving tablets there is a fear of choking due to its tablet type appearance. Hence oral film drug delivery is a better alternative in such cases. The oral films are formulated using polymers, plasticizers, flavors, colors and sweeteners. The oral films are manufactured using solvent casting method, rolling method, extrusion method and solid dispersion method. The films are evaluated for dimensions, disintegration, dissolution, tensile strength and folding endurance. It has many applications like in taste masking, immediate release and sustained release formulation INTRODUCTION Intraoral fast-dissolving drug delivery system is placed on Many pharmaceutical dosages are administered in the form the top or the floor of the tongue. It is retained at the site of of pills, granules, powders, and liquids. Generally, a pill application and rapidly releases the active agent for local design is for swallowing intact or chewing to deliver a and/or systemic absorption. This drug delivery system can precise dosage of medication to patients. The pills, which be provided in various packaging configurations, ranging include tablets and capsules, are able to retain their shapes from unit-dose pouches to multiple-dose blister packages.
    [Show full text]
  • Effect of Different Direct Compaction Grades of Mannitol on the Storage
    pharmaceutics Article Effect of Different Direct Compaction Grades of Mannitol on the Storage Stability of Tablet Properties Investigated Using a Kohonen Self-Organizing Map and Elastic Net Regression Model Atsushi Kosugi 1, Kok Hoong Leong 2, Eri Urata 3, Yoshihiro Hayashi 1, Shungo Kumada 1, Kotaro Okada 3 and Yoshinori Onuki 3,* 1 Formulation Development Department, Development & Planning Division, Nichi-Iko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa Namerikawa-shi, Toyama 936-0857, Japan; [email protected] (A.K.); [email protected] (Y.H.); [email protected] (S.K.) 2 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Malaya, Kuala Lumpur 50603, Malaysia; [email protected] 3 Laboratory of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama; 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan; [email protected] (E.U.); [email protected] (K.O.) * Correspondence: [email protected]; Tel.: +81-76-415-8827 Received: 21 August 2020; Accepted: 17 September 2020; Published: 18 September 2020 Abstract: This study tested 15 direct compaction grades to identify the contribution of different grades of mannitol to the storage stability of the resulting tablets. After preparing the model tablets with different values of hardness, they were stored at 25 ◦C, 75% relative humidity for 1 week. Then, measurement of the tablet properties was conducted on both pre- and post-storage tablets. The tablet properties were tensile strength (TS), friability, and disintegration time (DT). The experimental data were analyzed using a Kohonen self-organizing map (SOM).
    [Show full text]
  • Caph Cellulose Acetate Phthalate
    CAPh cellulose acetate phthalate PARAMETER UNIT VALUE REFERENCES GENERAL Common name - cellulose acetate phthalate, cellacefate Acronym - CAPh CAS number - 9004-38-0 RTECS number - FJ5692000 SYNTHESIS Monomer(s) structure - phthalic anhydride; partial acetate ester of cellulose Monomer(s) CAS number(s) - 85-44-9; 9004-35-7 Monomer(s) molecular weight(s) dalton, g/ 148.1; range mol, amu Acetyl content % 21.5-26 Phthalyl content % 30-36 Method of synthesis - partially substituted cellulose acetate is reacted with phthalic anhydride in the presence of an organic solvent and a basic catalyst Catalyst - base Number average molecular dalton, g/ 4,400-19,200 mol, amu weight, Mn Mass average molecular weight, dalton, g/ 2,500-65,900 mol, amu Mw STRUCTURE Crystallinity % 0, amorphous COMMERCIAL POLYMERS Some manufacturers - Eastman; FMC BioPolymer Trade names - Cellulose Acetate Phthalate; Aquacoat PHYSICAL PROPERTIES o -3 Bulk density at 20 C g cm 0.26 Color - white to off-white Odor odorless Melting temperature, DSC oC 192 pH solubility above 6.2 Glass transition temperature oC 145.59, 175 (Eastman) Bhat, K D; Jois, H S S, Procedia Mater. Sci., 5, 995-1004, 2014. MECHANICAL & RHEOLOGICAL PROPERTIES o -1 Intrinsic viscosity, 25 C dl g 0.2-0.6 Water absorption, equilibrium in % 2.2-5 water at 23oC CHEMICAL RESISTANCE Alcohols - poor Esters - poor Ketones - poor Good solvent - acetone:water=97:3, acetone:ethyl alcohol:50:50 PolymPart | http://www.polympart.com CAPh cellulose acetate phthalate PARAMETER UNIT VALUE REFERENCES FLAMMABILITY o Autoignition
    [Show full text]
  • A Review on Pharmaceutical Excipients
    Prasad Telaprolu. et al. / International Journal of Research in Pharmaceutical and Nano Sciences. 2(4), 2013, 423 - 431. Research Article CODEX: IJRPJK ISSN: 2319 – 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com A REVIEW ON PHARMACEUTICAL EXCIPIENTS Prasad Telaprolu 1* , M. Venkata Anjaneyulu 1, Y. Nagarjuna reddy 2 1*Department of Pharmaceutics, Narasaraopet Institute of Pharmaceutical Sciences, Narasaraopet, Guntur, Andhra Pradesh, India. 2Department of Pharmaceutics, Siddhartha Institute of Pharmaceutical Sciences, Narasaraopet, Guntur, Andhra Pradesh, India. ABSTRACT In addition to transporting the active drug to the site in the body where the drug is intended to exert its action, excipients play an important part in the manufacturing process. They may also be important for keeping the drug from being released too early in the assimilation process in places where it could damage tender tissue and create gastric irritation or stomach upset. In this review we discussed about all the excipients used in the pharmaceutical formulations. KEYWORDS Excipients, Active drug, Tissue, Gastric upset and Formulation. INTRODUCTION Author for Correspondence: Pharmaceutical excipient means any component other than the pharmacologically active drug which Prasad. Telaprolu, is included in the manufacturing process or is contained in a finished pharmaceutical product Department of Pharmaceutics, dosage form. Narasaraopet Institute of Pharmaceutical Sciences, While selecting excipients for any formulation following things should be considered wherever Narasaraopet, Guntur, Andhra Pradesh, India. possible: keep the excipients to a minimum in number minimize the quantity of each excipients and multifunctional excipients may be given preference Email: [email protected] over unifunctional excipients. Fewer ingredients in the formulation are better for the following reasons.
    [Show full text]
  • Excipients Used in Pharmaceutical Compounding Preparations Require Excipients to Impart a Variety of Properties to the Compounde
    Excipients Used in Pharmaceutical Compounding Preparations require excipients to impart a variety of properties to the compounded dosage form. From the compounder’s viewpoint, it is prudent to understand the role of each ingredient in the completed preparation. Many times this insight may alert the compounder to potential instabilities that might occur, clues about the preparation’s performance that would be useful/necessary to share with the patient, or provide alternatives if the preparation is not suitable for a patient due to allergies, preferences, etc. Also, excipients have different roles in different preparations, or oftentimes an excipient will play more than one role in a preparation. The list below is a compilation from several reference sources. It is not an all-inclusive list, nor does it provide an absolute classification scheme for all the excipients used in compounded preparations. It does serve as a basic template that can be expanded as desired. INGREDIENT TYPE DEFINITION EXAMPLES Acidifying agent Provides acidic medium for product stability in liquid Citric acid preparations. Acetic acid Fumaric acid Hydrochloric acid Nitric acid Alkalinizing agent Provides alkaline medium for product stability in Ammonia solution liquid preparations. Ammonium carbonate Diethanolamine Monoethanolamine Potassium hydroxide Sodium bicarbonate Sodium borate Sodium carbonate Sodium hydroxide Trolamine Adsorbent Holds other molecules onto its surface by physical or Powdered cellulose chemical (chemisorption) means. Activated charcoal Aerosol propellant Develops pressure within an aerosol container, which Carbon dioxide expels the ingredients when the valve is opened. Dichlorodifluoromethane Dichlorotetrafluoroethane Trichloromonofluoromethane Air displacement Displaces air in a hermetically sealed container to Nitrogen enhance product stability. Carbon dioxide Antifoaming agent Breaks up and inhibits the formation of foams.
    [Show full text]